Market Research on Radiation Therapy system Paper

marketplace on Radiation Therapy agreement - Research Paper ExampleAccurays commercial release of installed theme systems has increased from zero to approximately 600 systems in a decade. These sales have been recorded mainly in the United States and internationally. The high release is as a result of the growing demand for efficient and rough-and-ready radiation therapy in the market. The development of clinical evidence that support the merits of IMRT and image-guided radiotherapy is also a march on to this technology (Faiz 140). Manufacturers of Radiation Therapy systems Accuray in the third quarter of financial 2013 recorded an increase in unsanded orders. The corporation has also installed TomoTherapy H series and the untried Cyber-knife M6 series systems. These installations have led to an increase in the gross profit and an improvement in service revenue. A gross total of $53.8 jillion of new product orders have been recorded in the third quarter of fiscal 2013. The s econd quarter of fiscal 2013 had a gross product orders totaling to $39.8 one one thousand thousand million million. The net income product orders in the third quarter of fiscal 2013 amounted to $44.1 million as compared to the previous quarter with $17.9 million. The company has also recorded ending product backlog of $279.9 million marking a 7% increase from the previous quarter. ... Varian company attained net orders worth $3,122 million and recorded a total of $2,807 million revenue last form. These records show an increase in net orders from $2,933 and an increase in revenue from $2,597 in the previous year. The operating earnings of the company in the fiscal 2011 totaled $588 million which increased to $594 million in fiscal 2012. Net earnings in fiscal 2012 were $427 million from $409 million in the previous year. Elekta Oncology Systems Inc. manufactures integrated x-ray systems, linear accelerators with multileaf collimators and offers clinical solutions for patient alt ering and positioning (Arno and Roeske ampere-second). It supplies its products to cancer centers, universities and hospitals. The corporation is famous for introducing critical technological advances in the radiotherapy field. The company focuses on evidence-based medicine with the aim of saving and prolonging life. Some of the techniques used by Elekta are Stereotactic radiation therapy, Image point Radiotherapy, beam shaping and motion management (David et al 730). The company expects the net sales of the fiscal year 2012/1013 to increase by 15% in local currency. It expects an increase of operating profit by oer 15% despite effects of exchange rates volatility. The company recorded a total of$1.46 one thousand thousand and a net income of $0.16 billion. Costs Radiation Therapy systems X-ray radiation therapy system costs about $10 million and requires less space as compared to particle beam therapies whose facility cost up to $100 million. Varian Inc. holds approximately 60% of the international market share of radiation oncology equipment. A brand new system costs $2-3